Copyright
©The Author(s) 2025.
World J Clin Oncol. Mar 24, 2025; 16(3): 101251
Published online Mar 24, 2025. doi: 10.5306/wjco.v16.i3.101251
Published online Mar 24, 2025. doi: 10.5306/wjco.v16.i3.101251
Characteristics | HR | 95%CI | P value |
Therapeutic effectiveness of induction therapy | |||
Partial response | 1.000 | ||
Stable disease | 2.113 | 1.113-4.013 | 0.022 |
PTV dose | |||
≤ 50 Gy | 1.000 | ||
> 50 Gy | 0.620 | 0.300-1.284 | 0.198 |
Maintenance of immunotherapy | |||
Yes | 1.000 | ||
No | 0.402 | 0.185-0.957 | 0.039 |
- Citation: Wei ZJ, Wang L, Wang RQ, Wang Y, Chen H, Ma HL, Xu YJ. Safety and effectiveness of induction chemoimmunotherapy followed by definitive radiotherapy or concurrent chemoradiotherapy in esophageal squamous cell carcinoma. World J Clin Oncol 2025; 16(3): 101251
- URL: https://www.wjgnet.com/2218-4333/full/v16/i3/101251.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i3.101251